Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Clinical Chemistry and Laboratory Medicine|December 11, 2019
Childhood obesity: an overview of laboratory medicine, exercise and microbiomeOlga Scudiero, Raffaela Pero, Annaluisa Ranieri, et al.
Heart Failure Clinics|November 15, 2021
Hypertrophic Cardiomyopathy in RASopathies: Diagnosis, Clinical Characteristics, Prognostic Implications, and ManagementMichele Lioncino, Emanuele Monda, Federica Verrillo, et al.
International Journal of Cardiology|October 25, 2021
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registryArturo Cesaro, Felice Gragnano, Paolo Calabrò, et al.
Journal of Clinical Medicine|April 28, 2023
Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary PerspectiveFelice Gragnano, Francesco Pelliccia, Natale Guarnaccia, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Pathophysiology and Treatment of the No-Reflow Phenomenon in ST-Segment Elevation Myocardial Infarction: Focus on Low-Dose Fibrinolysis during Primary Percutaneous InterventionFrancesco Pelliccia, Giampaolo Niccoli, Marco Zimarino, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 23, 2018
Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study)Elisabetta Moscarella, Akihito Tanaka, Alfonso Ielasi, et al.
Journal of Clinical Medicine|January 11, 2024
Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionFelice Gragnano, Antonio Capolongo, Antonio Micari, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 15, 2024
Five-year clinical outcomes of STEMI patients treated with a pre-specified bioresorbable vascular scaffold implantation technique: Final results of the BVS STEMI STRATEGY-ITElisabetta Moscarella, Gianluca Campo, Massimo Leoncini, et al.
International Journal of Molecular Sciences|May 13, 2023
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical PracticeArturo Cesaro, Vincenzo Acerbo, Erica Vetrano, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 3, 2017
One-year clinical outcomes after unrestricted implantation of the Absorb bioresorbable scaffold (RAI registry)Alfonso Ielasi, Bernardo Cortese, Elisabetta Moscarella, et al.
Pageof 9